Integrated Decision Support for Assessing Chemical Liabilities

Chemical liabilities, such as adverse effects and toxicity, have a major impact on today's drug discovery process. In silico prediction of chemical liabilities is an important approach which can reduce costs and animal testing by complementing or replacing in vitro and in vivo liability models. There is a lack of integrated, extensible decision support systems for chemical liability assessment which run quickly and have easily interpretable results. Here we present a method which integrates similarity searches, structural alerts, and QSAR models which all are available from the Bioclipse workbench. Emphasis has been placed on interpretation of results, and substructures which are important for predictions are highlighted in the original chemical structures. This allows for interactively changing chemical structures with instant visual feedback and can be used for hypothesis testing of single chemical structures as well as compound collections. The system has a clear separation between methods and data, and the extensible architecture enables straightforward extension via addition of more plugins (such as new data sets and computational models). We demonstrate our method on three important safety end points: mutagenicity, carcinogenicity, and aryl hydrocarbon receptor (AhR) activation. Bioclipse and the decision support implementation are free, open source, and available from http://www.bioclipse.net/decision-support .

[1]  Egon L. Willighagen,et al.  Bioclipse 2: A scriptable integration platform for the life sciences , 2009, BMC Bioinformatics.

[2]  Egon L. Willighagen,et al.  The Chemistry Development Kit (CDK): An Open-Source Java Library for Chemo-and Bioinformatics , 2003, J. Chem. Inf. Comput. Sci..

[3]  C. Hansch Quantitative approach to biochemical structure-activity relationships , 1969 .

[4]  J. Ashby Fundamental structural alerts to potential carcinogenicity or noncarcinogenicity. , 1985, Environmental mutagenesis.

[5]  Joel T Dudley,et al.  In silico research in the era of cloud computing , 2010, Nature Biotechnology.

[6]  W. Alkema,et al.  Literature-based compound profiling: application to toxicogenomics. , 2007, Pharmacogenomics.

[7]  Bethan Hughes,et al.  2009 FDA drug approvals , 2010, Nature Reviews Drug Discovery.

[8]  David S. Wishart,et al.  DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..

[9]  R. Fitzpatrick CPDB: Carcinogenic Potency Database , 2008, Medical Reference Services Quarterly.

[10]  Robert D. Carr,et al.  The Signature Molecular Descriptor. 4. Canonizing Molecules Using Extended Valence Sequences , 2004, J. Chem. Inf. Model..

[11]  Jean-Loup Faulon,et al.  The Signature Molecular Descriptor. 1. Using Extended Valence Sequences in QSAR and QSPR Studies , 2003, J. Chem. Inf. Comput. Sci..

[12]  A M Richard,et al.  Structure-based methods for predicting mutagenicity and carcinogenicity: are we there yet? , 1998, Mutation research.

[13]  John M. Barnard,et al.  Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..

[14]  Luis G Valerio,et al.  In silico toxicology for the pharmaceutical sciences. , 2009, Toxicology and applied pharmacology.

[15]  Scott Boyer,et al.  Interpretation of Nonlinear QSAR Models Applied to Ames Mutagenicity Data , 2009, J. Chem. Inf. Model..

[16]  J. Kazius,et al.  Derivation and validation of toxicophores for mutagenicity prediction. , 2005, Journal of medicinal chemistry.

[17]  R Benigni,et al.  Chemical structure of mutagens and carcinogens and the relationship with biological activity. , 2004, Journal of experimental & clinical cancer research : CR.

[18]  H. van de Waterbeemd,et al.  ADMET in silico modelling: towards prediction paradise? , 2003, Nature reviews. Drug discovery.

[19]  Ann M Richard,et al.  Distributed structure-searchable toxicity (DSSTox) public database network: a proposal. , 2002, Mutation research.

[20]  Subhash C. Basak,et al.  Molecular Similarity and Estimation of Molecular Properties , 1995, J. Chem. Inf. Comput. Sci..

[21]  G. Zlokarnik,et al.  In silico prediction of drug safety: despite progress there is abundant room for improvement. , 2004, Drug discovery today. Technologies.

[22]  Egon L. Willighagen,et al.  XMPP for cloud computing in bioinformatics supporting discovery and invocation of asynchronous web services , 2009, BMC Bioinformatics.

[23]  Scott Boyer,et al.  A Method for Automated Molecular Optimization Applied to Ames Mutagenicity Data , 2009, J. Chem. Inf. Model..

[24]  Henry S Rzepa,et al.  Enhancement of the chemical semantic web through the use of InChI identifiers. , 2005, Organic & biomolecular chemistry.

[25]  C. Steinbeck,et al.  Recent developments of the chemistry development kit (CDK) - an open-source java library for chemo- and bioinformatics. , 2006, Current pharmaceutical design.

[26]  E. Zeiger,et al.  The Ames Salmonella/microsome mutagenicity assay. , 2000, Mutation research.

[27]  Yvonne C. Martin,et al.  Application of Belief Theory to Similarity Data Fusion for Use in Analog Searching and Lead Hopping , 2008, J. Chem. Inf. Model..

[28]  M. Denison,et al.  Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. , 2003, Annual review of pharmacology and toxicology.

[29]  John C. Dearden,et al.  In silico prediction of drug toxicity , 2003, J. Comput. Aided Mol. Des..

[30]  Egon L. Willighagen,et al.  Bioclipse: an open source workbench for chemo- and bioinformatics , 2007, BMC Bioinformatics.